Valencia Nutrition Limited (BOM:542910)

MorphoSys AG Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	10.74	-13.85	-12.63	-6.62	-35.76
Depreciation & Amortization	2.12	0.52	0.74	0.76	1.34
Loss (Gain) From Sale of Assets	-	-	-	0.16	0.37
Provision & Write-off of Bad Debts	-	-	-	-	0.06
Other Operating Activities	-4.12	0.3	-	0.07	9.19
Change in Accounts Receivable	-55.1	-6.78	-2.34	-0.36	-0.04
Change in Inventory	-19.63	1.4	-7.57	-	3.14
Change in Accounts Payable	-1.11	-0.75	0.99	-3.4	1.68
Change in Other Net Operating Assets	-127.25	11.59	5.29	-4.11	-4.9
Operating Cash Flow	-194.35	-7.56	-15.53	-13.49	-24.92
Capital Expenditures	-40.8	-22.25	-	-	-1.16
Sale of Property, Plant & Equipment	-	-	-	11.21	-
Investment in Securities	-29.28	-	-	-	-
Other Investing Activities	5.44	-	-	0	0.23
Investing Cash Flow	-64.64	-22.25	-	11.22	-0.93
Long-Term Debt Issued	-	31.59	15.83	4.18	-
Total Debt Issued	-	31.59	15.83	4.18	-
Long-Term Debt Repaid	-38.53	-	-	-	-0.82
Net Debt Issued (Repaid)	-38.53	31.59	15.83	4.18	-0.82
Other Financing Activities	374.27	-0.3	-	0.07	-0.9
Financing Cash Flow	335.74	31.28	15.83	4.25	-1.72
Miscellaneous Cash Flow Adjustments	-	-	-	-0	-0
Net Cash Flow	76.75	1.48	0.3	1.97	-27.58
Free Cash Flow	-235.15	-29.81	-15.53	-13.49	-26.09
Free Cash Flow Margin	-277.60%	-223.22%	-106.31%	-	-273.22%
Free Cash Flow Per Share	-16.64	-5.34	-2.78	-2.42	-4.67
Cash Interest Paid	1.31	0.3	-	-	-
Levered Free Cash Flow	-197.99	-22.75	-10.68	-10.91	-16.51
Unlevered Free Cash Flow	-197.17	-22.56	-10.68	-10.86	-15.95
Change in Net Working Capital	166.03	-7.64	3.52	7.63	-2.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.